03.07.2009TIME: 17:35:01
LAST
11,85 €
OPEN
11,70 €
CHANGE
+0,42%»
COMPANY PIPELINE NEWS INVESTOR RELATIONS   Search
  mission statement
 
COMPANY COMPANY
  ThromboGenics is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company has used ... more »  
 
English
Nederlands
English
Nederlands
COMPANY
PIPELINE PIPELINE
  ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more »  
  foto2 Pipeline overview
NEWS & EVENTS NEWS & EVENTS
 

July 3, 2009

ThromboGenics and BioInvent start recruitment of second 100 patient cohort in Phase II study..more »

ThromboGenics en BioInvent starten rekrutering tweede groep van 100 patiënten in fase II studie.. meer »

Physicians and Investigators interested in participating in the Phase III microplasmin studies, please contact the MIVI-TRUST team... more »

 
  All rights reserved © Thrombogenic 2006 Last update: July 3, 2009 Inspired by Echo
 
PIPELINE COMPANY Pipeline overview